FDA Drug recall D-0312-2024
Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd
- FDA Drug
- Class III
- ongoing
- Published 2024-02-14
On 2024-02-14 the FDA classified a Class III recall of Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd by Dr Reddy S Laboratories, citing misprint on tablet.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0312-2024 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2024-01-18 |
| Published | 2024-02-14 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-01
Reason
Misprint on tablet
Identifiers
| ndc | 55111-320-30 |
|---|---|
| ndc | 55111-320-01 |
| ndc | 55111-320-05 |
| ndc | 55111-320-79 |
| ndc | 55111-320-78 |
| ndc | 55111-321-30 |
| ndc | 55111-321-01 |
| ndc | 55111-321-05 |
| ndc | 55111-321-79 |
| ndc | 55111-321-78 |
| ndc | 55111-322-30 |
| ndc | 55111-322-01 |
| ndc | 55111-322-05 |
| ndc | 55111-322-79 |
| ndc | 55111-322-78 |
| code_info | Lot: T2303622; Exp. 06/2026 Lot: T2303626; Exp. 06/2026 Lot: T2303627; Exp. 06/2026 Lot: T2303628; Exp. 06/2026 Lot: T2303629; Exp. 06/2026 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0312-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.